Another example of biomimetic engineering involves apoA1-bExo, an exosome functionalized with the tumor-targeting apolipoprotein A1 (apoA1), used to deliver siRNA targeting neutral sphingomyelinase 2 (nSMase2), an enzyme implicated in exosomal PD-L1 secretion. Here, SMPD3 is linked to neoplasm.